SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-21-283732
Filing Date
2021-09-27
Accepted
2021-09-27 11:04:01
Documents
14
Period of Report
2021-09-27
Items
Item 7.01: Regulation FD Disclosure
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d164359d8k.htm   iXBRL 8-K 27116
2 EX-99.1 d164359dex991.htm EX-99.1 12145
6 GRAPHIC g164359g0925074302739.jpg GRAPHIC 3726
  Complete submission text file 0001193125-21-283732.txt   168340

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA ccxi-20210927.xsd EX-101.SCH 2903
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE ccxi-20210927_lab.xml EX-101.LAB 17373
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE ccxi-20210927_pre.xml EX-101.PRE 10960
7 EXTRACTED XBRL INSTANCE DOCUMENT d164359d8k_htm.xml XML 3231
Mailing Address 835 INDUSTRIAL ROAD SUITE 600 SAN CARLOS CA 94070
Business Address 835 INDUSTRIAL ROAD SUITE 600 SAN CARLOS CA 94070 650-210-2900
ChemoCentryx, Inc. (Filer) CIK: 0001340652 (see all company filings)

IRS No.: 943254365 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-35420 | Film No.: 211279853
SIC: 2834 Pharmaceutical Preparations